DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to invest in for the next 2 years. On April 30, DexCom reported Q1 ...

DexCom has barely scratched the surface of its niche in the diabetes market. As a result of industry challenges, the stock's valuation has now come down. But from here, the stock looks well-positioned ...

While GLP-1 agonists have grabbed investor attention for their potential as weight loss aids, these medicines also form a ...

They offer investors very different value propositions.

Add Yahoo as a preferred source to see more of our stories on Google. (COLORADO SPRINGS) — A medical device for diabetes called the Dexcom is facing a national shortage that’s now leaving diabetics in ...

Add Yahoo as a preferred source to see more of our stories on Google. (COLORADO SPRINGS) — FOX21 News has learned alternative ways people are getting around the shortage of the medical device called ...

Medical device maker Dexcom on Thursday reiterated its full-year revenue forecast after beating Wall Street estimates for ...

Medical device company DexCom (NASDAQ:DXCM) reported Q1 CY2026 results , with sales up 15% year on year to $1.19 billion. The ...

Glucose-monitoring specialist Dexcom announced it is expanding its diabetes-management capabilities by offering direct connectivity to the Apple Watch for its G7 continuous glucose monitoring system ...

Dexcom has opted not to raise its FY26 revenue outlook due to the current geopolitical environment.

San Diego device maker Dexcom has received the first FDA clearance for a continuous glucose monitor that doesn’t require a doctor’s prescription. The U.S. Food and Drug Administration cleared Dexcom’s ...

Dexcom's devices could become even more popular thanks to weight loss drugs. The company has a vast addressable market. The ...